BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8339601)

  • 1. In vitro leucocytotoxicity of alpha-hemolytic Escherichia coli.
    Gadeberg OV
    Dan Med Bull; 1993 Jun; 40(3):295-305. PubMed ID: 8339601
    [No Abstract]   [Full Text] [Related]  

  • 2. [Escherichia coli hemolysin: secretion kinetics and cytotoxic effect].
    Abacioğlu H; Yuluğ N
    Mikrobiyol Bul; 1993 Oct; 27(4):284-93. PubMed ID: 8264441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes. Correlation with size of alpha-hemolysin production.
    Gadeberg OV; Larsen SO
    APMIS; 1988 Apr; 96(4):337-41. PubMed ID: 2897205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental regulation of alpha-haemolysin expression in Escherichia coli.
    Mouriño M; Muñoa F; Balsalobre C; Diaz P; Madrid C; Juarez A
    Microb Pathog; 1994 Apr; 16(4):249-59. PubMed ID: 7968454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Escherichia coli alpha-hemolysin to bacterial virulence and to intraperitoneal alterations in peritonitis.
    May AK; Gleason TG; Sawyer RG; Pruett TL
    Infect Immun; 2000 Jan; 68(1):176-83. PubMed ID: 10603385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.
    Gleason TG; Houlgrave CW; May AK; Crabtree TD; Sawyer RG; Denham W; Norman JG; Pruett TL
    Infect Immun; 1998 Sep; 66(9):4215-21. PubMed ID: 9712770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the roles of hemolysin and other toxins in enteropathy caused by alpha-hemolytic Escherichia coli linked to human diarrhea.
    Elliott SJ; Srinivas S; Albert MJ; Alam K; Robins-Browne RM; Gunzburg ST; Mee BJ; Chang BJ
    Infect Immun; 1998 May; 66(5):2040-51. PubMed ID: 9573087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants.
    May AK; Sawyer RG; Gleason T; Whitworth A; Pruett TL
    Infect Immun; 1996 Jun; 64(6):2167-71. PubMed ID: 8675322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial hemolysins and leukotoxins affect target cells by forming large exogenous pores into their plasma membrane: Escherichia coli hemolysin A as a case example.
    Menestrina G; Dalla Serra M; Pederzolli C; Bregante M; Gambale F
    Biosci Rep; 1995 Dec; 15(6):543-51. PubMed ID: 9156583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxigenic Escherichia coli.
    Chart H
    Symp Ser Soc Appl Microbiol; 1998; 27():77S-86S. PubMed ID: 9750364
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of phagocytosis of alpha hemolytic strains of Escherichia coli using the fluorescence method].
    Siegfried L; Puzová H; Hlaucová J; Durovicová J
    Cesk Epidemiol Mikrobiol Imunol; 1989 Jul; 38(4):204-8. PubMed ID: 2676198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolysins and verotoxin (VT) in enteric Escherichia coli isolated from pigs.
    Zamora J; Reinhardt G; Polette M; Macías P
    Rev Latinoam Microbiol; 1997; 39(3-4):159-65. PubMed ID: 10932726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction fragment length polymorphisms associated with alpha-hemolysin determinants are correlating with the expression of alpha-hemolysin in strains of Escherichia coli.
    Prada J; Zimmermann S; Stephan R; Beutin L
    Zentralbl Bakteriol; 1992 Jan; 276(2):152-64. PubMed ID: 1348436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acylation of two internal lysine residues required for the toxic activity of Escherichia coli hemolysin.
    Stanley P; Packman LC; Koronakis V; Hughes C
    Science; 1994 Dec; 266(5193):1992-6. PubMed ID: 7801126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic applications of pore-forming lytic toxins: potential use of Escherichia coli alpha-hemolysin].
    Herlax V; Bakas LS
    Medicina (B Aires); 2002; 62(1):66-72. PubMed ID: 11965855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum resistance of Escherichia coli strains causing urinary tract infection and diarrhoea in relation to alpha haemolysin production and O type.
    Rizvi M; Kumar S
    Indian J Pathol Microbiol; 2003 Jul; 46(3):504-6. PubMed ID: 15025325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of sepsis syndrome: possible relevance of pore-forming bacterial toxins.
    Bhakdi S; Walev I; Jonas D; Palmer M; Weller U; Suttorp N; Grimminger F; Seeger W
    Curr Top Microbiol Immunol; 1996; 216():101-18. PubMed ID: 8791737
    [No Abstract]   [Full Text] [Related]  

  • 18. The biochemistry of hemolysin toxin activation: characterization of HlyC, an internal protein acyltransferase.
    Trent MS; Worsham LM; Ernst-Fonberg ML
    Biochemistry; 1998 Mar; 37(13):4644-52. PubMed ID: 9521785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis and function of the Escherichia coli hemolysin and related RTX exotoxins.
    Welch RA; Forestier C; Lobo A; Pellett S; Thomas W; Rowe G
    FEMS Microbiol Immunol; 1992 Sep; 5(1-3):29-36. PubMed ID: 1419112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dangerous signals from E. coli toxin.
    Ludwig A; Goebel W
    Nat Med; 2000 Jul; 6(7):741-2. PubMed ID: 10888915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.